Enveric Biosciences, Inc. Common Stock
Symbol: ENVB (NASDAQ)
0.65
▲ (1.81%) 0.012
Company Description:
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
Key Stats
- Today's Open: $0.65
- Today's High: $0.658
- Today's Low: $0.615
- Today's Volume: 172.40K
- Yesterday Close: $0.6394
- Yesterday High: $0.675
- Yesterday Low: $0.59
- Yesterday Volume: 540.41K
- Last Min Volume: 50
- Last Min High: $0.651
- Last Min Low: $0.651
- Last Min VWAP: $0.651
Company Profile
- Name: Enveric Biosciences, Inc. Common Stock
- Website: https://www.enveric.com
- Listed Date: 1995-08-24
- Location: NAPLES, FL
- Market Status: Active
- CIK Number: 0000890821
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.98M
- Round Lot: 100
- Outstanding Shares: 6.22M
- Asset Type: CS
RECENT FILINGS FOR ENVB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-29 | S-3 | View |
| 2025-09-24 | SCHEDULE 13G | View |
| 2025-09-18 | 8-K | View |
| 2025-09-02 | 8-K | View |
| 2025-08-29 | 8-K | View |
| 2025-08-29 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-06-03 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-14 | 8-K | View |
| 2025-05-12 | 4 | View |
| 2025-05-12 | 4 | View |
| 2025-05-12 | 4 | View |
| 2025-04-17 | EFFECT | View |
| 2025-04-16 | CORRESP | View |
| 2025-04-16 | ARS | View |
| 2025-04-15 | DEFA14A | View |
| 2025-04-15 | DEF 14A | View |
| 2025-04-14 | 8-K | View |
Latest News on ENVB